Summary
The pharmacokinetics of a single i. v. dose of dlbisoprolol 0.16 mg·kg−1 ideal body weight has been studied in 8 obese women (mean weight 91 kg; 161% of ideal body weight) and 8 non-obese women (51 kg; 94% of ideal body weight).
Compared to the controls, the obese subjects showed an increase in the total apparent volume of distribution (Vz) (182 vs 135 1) and a decrease in Vz per kg body weight (2 vs 2.7 l·kg−1). There was a negative correlation between Vz l·kg−1 and the percentage of ideal body weight (r=−0.672). Total body clearance was increased, but t1/2 and renal clearance was unchanged.
It is concluded that tissue diffusion of bisoprolol in obese subjects is limited, despite its lipophilicity, possibly because of alteration in the blood flow to adipose tissue produced by bisoprolol.
Similar content being viewed by others
References
Cheymol G (1988) Drug pharmacokinetics in the obese. Fundam Clin Pharmacol 2: 239–256
Abernethy DR, Greenblatt DJ (1986) Drug disposition in obese humans: an update. Clin Pharmacokinet 11: 199–213
Abernethy DR, Greenblatt DJ, Divoll M, Harmatz JS, Shader RI (1981) Alterations in drug disposition and clearance due to obesity. J Pharmacol Exp Ther 217: 681–685
Abernethy DR, Greenblatt DJ, Smith TB (1981) Digoxin disposition in obesity: clinical pharmacokinetic investigation. Am Heart J 102: 740–744
Bowman SL, Hudson SA, Simpson G, Munro JF, Clements JA (1986) A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. Br J Clin Pharmacol 21: 529–532
Cheymol G, Poirier JM, Barré J, Pradalier A, Dry J (1987) Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers. J Clin Pharmacol 27: 874–879
Anonymous (1959) Weights of insured persons in the United States associated with lowest mortality. Stat Bull Metrop Insur Co 40 November–December
Hinderliter AL, Fitzpatrick MA, Schork N, Julius S (1987) Research utility of non-invasive methods for measurement of cardiac output. Clin Pharmacol Ther 41: 419–425
Poirier JM, Perez M, Cheymol G, Jaillon P (1988) Rapid and sensitive high performance liquid chromatographic determination of bisoprolol in plasma and urine. J Chromatogr 426: 431–437
Gomeni R (1984) Pharm: an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med 14: 25–34
Leopold G (1986) Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol 8 [Suppl 11]: S16-S20
Leopold G, Pabst J, Ungethum W, Burhing KU (1987) Basic pharmacokinetics of bisoprolol a new highly β1 selective adrenoreceptor antagonist, J Clin Pharmacol 26: 616–621
Womersley J, Durnin J, Body K, Mahaffly M (1976) Influence of muscular development, obesity and age on the fat free mass of adults. J Appl Physiol 41: 223–229
Woods PB, Robinson ML (1981) An investigation of the comparative liposolubilities of β-adrenoreceptor blocking agents. J Pharm Pharmacol 33: 172–173
Messerli FH, Sundgoard-Russe K, Reisin E, Dreslinski G, Dunn FG, Frohlich E (1983) Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 74: 808–812
Belfrage E (1978) Vasodilatation and modulation of vasoconstriction in canine subcutaneous adipose tissue caused by activation of βadrenoreceptors. Acta Physiol Scand 102: 459–468
Rosell S, Belfrage E (1979) Blood circulation in adipose tissue. Phys Res 59: 1078–1104
Krämer B, Balser J, Stubbig K, Krämer G, Kübler WY (1986) Comparison of bisoprolol with other β-adrenoceptor blocking drugs. J Cardiovasc Pharmacol 8 [Suppl 11]: S46-S57
Chang PC, Van Veen S, Vermeij P, Van Brummelen P (1986) Double-blind comparison of the β1-selectivity of single doses of bisoprolol and atenolol. J Cardiovasc Pharmacol 8 [Suppl 11]: S58-S60
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Le Jeunne, C., Poirier, J.M., Cheymol, G. et al. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers. Eur J Clin Pharmacol 41, 171–174 (1991). https://doi.org/10.1007/BF00265912
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265912